Zeng et al. (2019) developed a non-viral gene therapy for RDEB using nanoparticles made of highly branched poly(b-amino ester) (HPAEs) and minicircle DNA (mcDNA) encoding COL7A1. Here, COL7A1 is linked to recessive dystrophic epidermolysis bullosa.